RAFAEL HOLDINGS, INC. Equity Securities, FV-NI, Realized Gain (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Equity Securities, FV-NI, Realized Gain (Loss) of $334.00 thousand for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $334.00K.
- RAFAEL HOLDINGS, INC. equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|
| 2023-07-31 | $334.00K 10-K · filed 2023-10-30 |
| 2022-07-31 | $0.00 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |